Your browser doesn't support javascript.
loading
Long-lasting severe immune dysfunction in Ebola virus disease survivors.
Wiedemann, Aurélie; Foucat, Emile; Hocini, Hakim; Lefebvre, Cécile; Hejblum, Boris P; Durand, Mélany; Krüger, Miriam; Keita, Alpha Kabinet; Ayouba, Ahidjo; Mély, Stéphane; Fernandez, José-Carlos; Touré, Abdoulaye; Fourati, Slim; Lévy-Marchal, Claire; Raoul, Hervé; Delaporte, Eric; Koivogui, Lamine; Thiébaut, Rodolphe; Lacabaratz, Christine; Lévy, Yves.
Afiliação
  • Wiedemann A; INSERM U955 Team 16, Vaccine Research Institute, Faculté de Médecine, Université Paris-Est Créteil, Créteil, France.
  • Foucat E; INSERM U955 Team 16, Vaccine Research Institute, Faculté de Médecine, Université Paris-Est Créteil, Créteil, France.
  • Hocini H; INSERM U955 Team 16, Vaccine Research Institute, Faculté de Médecine, Université Paris-Est Créteil, Créteil, France.
  • Lefebvre C; INSERM U955 Team 16, Vaccine Research Institute, Faculté de Médecine, Université Paris-Est Créteil, Créteil, France.
  • Hejblum BP; Department of Public Health, Inserm Bordeaux Population Health Research Centre, Univ. Bordeaux, Inria SISTM, UMR 1219, Vaccine Research Institute (VRI), Créteil, France.
  • Durand M; Department of Public Health, Inserm Bordeaux Population Health Research Centre, Univ. Bordeaux, Inria SISTM, UMR 1219, Vaccine Research Institute (VRI), Créteil, France.
  • Krüger M; Department of Public Health, Inserm Bordeaux Population Health Research Centre, Univ. Bordeaux, Inria SISTM, UMR 1219, Vaccine Research Institute (VRI), Créteil, France.
  • Keita AK; TransVIHMI, IRD UMI 233, INSERM U1175, Montpellier University, Montpellier, France.
  • Ayouba A; CERFIG, Gamal Nasser University, Conakry, Guinea.
  • Mély S; TransVIHMI, IRD UMI 233, INSERM U1175, Montpellier University, Montpellier, France.
  • Fernandez JC; Laboratoire P4 Inserm-Jean Mérieux, US003 INSERM, Lyon, France.
  • Touré A; INSERM U955 Team 16, Vaccine Research Institute, Faculté de Médecine, Université Paris-Est Créteil, Créteil, France.
  • Fourati S; TransVIHMI, IRD UMI 233, INSERM U1175, Montpellier University, Montpellier, France.
  • Lévy-Marchal C; CERFIG, Gamal Nasser University, Conakry, Guinea.
  • Raoul H; Institut National de Santé Publique (INSP), Conakry, Guinea.
  • Delaporte E; Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert-Chenevier, Laboratoire de Virologie, Créteil, France.
  • Koivogui L; Pôle de Recherche Clinique (PRC), INSERM, Paris, France.
  • Thiébaut R; Laboratoire P4 Inserm-Jean Mérieux, US003 INSERM, Lyon, France.
  • Lacabaratz C; TransVIHMI, IRD UMI 233, INSERM U1175, Montpellier University, Montpellier, France.
  • Lévy Y; Institut National de Santé Publique (INSP), Conakry, Guinea.
Nat Commun ; 11(1): 3730, 2020 07 24.
Article em En | MEDLINE | ID: mdl-32709840
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Ebolavirus / Doenças do Sistema Imunitário Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Ebolavirus / Doenças do Sistema Imunitário Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França